| 
Results for syr322. Search took 0.06 seconds.
Takeda Filed for US Approval of Diabetes Drug Alogliptin
in Daily Diabetic, on January 4, 2008
The Japanese pharmaceutical company - Takeda - announced that it is seeking U.S. approval of its diabetes Drug Alogliptin (SYR-322) .
Alogliptin is a diabetes drug that Takeda hopes to replace Actos (Pioglitazone HCl) - another Takeda diabetes drug.
[Alogliptin, or SYR-322, is in ...